Facts
Medical Cannabis in Europe
Look at the data on the European Medical Cannabis Market
Facts
Medical Cannabis In Europe
The European cannabis market will be worth €403.4 million by the end of 2021 and will grow at a compound annual growth rate (CAGR) of 67.4% from 2021 to reach €3.2 billion by 2025.
- The EU medical markets are growing at rapid pace – and price levels are significantly higher than in other markets
- More and more countries introduce regulatory frameworks to allow medical cannabis and different product formats (flowers, extracts, dronabinol, …) – often times the costs are covered by health insurance
- In addition, the opening of recreational markets has been initiated in some smaller countries (e.g., Luxemburg but also Spain) and it is expected that the larger countries (e.g., Germany) will follow soon – there is a robust majority in most countries pushing for legalization
Projected growth of European cannabis market
Sales in Millions of USD
CAGR
56%
Projected sales of medical cannabis in Europe
Sales in Millions of USD
Legal Framework
Path to legalization for medical cannabis in EU
Enhancing the security of supplies, increasing the variety of offers, driving innovation – this is how Cantourage aims to make lasting mark on the European medical cannabis markets.
Previous
Next
Germany
major market segments
- In general, the European medical cannabis markets may be divided into four distinct segments: dried flowers, extracts, dronabinol, and finished products
- Some countries have already implemented a regulatory framework that allows doctors to prescribe products from each segment (e.g., Germany) – other only allow some segments or specific prodicts (e.g., Austria)
- In principle, dried flowers tends to be the dominating segments (>40%) in all European medical cannabis markets – but also in the rather mature ones in the US and Canada
Germany
Dried Flowers
Quantity of dried flower imported to Germany
(in kg)